Aqua Bio Technology ASA (STU:3FZ0) Debt-to-EBITDA : N/A (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:3FZ0 Aqua Bio Technology ASA STU:3FZ0
43 GF Score
Price €0.45
GF Value €0.27
! 6 Warning Signs
View Full Analysis

What is Aqua Bio Technology ASA Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aqua Bio Technology ASA's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €0.00 Mil. Aqua Bio Technology ASA's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2026 was €6.60 Mil. Aqua Bio Technology ASA's annualized EBITDA for the quarter that ended in Jun. 2026 was €0.00 Mil.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Aqua Bio Technology ASA's Debt-to-EBITDA or its related term are showing as below:

STU:3FZ0' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -19   Med: -0.24   Max: 50.92
Current: 50.92

During the past 13 years, the highest Debt-to-EBITDA Ratio of Aqua Bio Technology ASA was 50.92. The lowest was -19.00. And the median was -0.24.

STU:3FZ0's Debt-to-EBITDA is ranked worse than
97.38% of 305 companies
in the Biotechnology industry
Industry Median: 1.24 vs STU:3FZ0: 50.92

Aqua Bio Technology ASA  (STU:3FZ0) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.


Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.


Aqua Bio Technology ASA Debt-to-EBITDA Related Terms


Aqua Bio Technology ASA Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for Aqua Bio Technology ASA's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aqua Bio Technology ASA Debt-to-EBITDA Chart

Aqua Bio Technology ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Debt-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.43 -1.14 -4.16 2.89 -18.99

Aqua Bio Technology ASA Quarterly Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Sep24 Dec24 Jun25 Sep25 Dec25 Jun26
Debt-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.54 N/A -33.84 12.16 N/A

STU:3FZ0 vs VRTX, REGN, MRNA: Debt-to-EBITDA Comparison

For the Biotechnology subindustry, Aqua Bio Technology ASA's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aqua Bio Technology ASA Debt-to-EBITDA vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Aqua Bio Technology ASA's Debt-to-EBITDA falls into.


STU:3FZ0
43GF Score
Aqua Bio Technology ASA STU:3FZ0
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aqua Bio Technology ASA Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Aqua Bio Technology ASA's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(9.191 + 0) / -0.484
=-18.99

Aqua Bio Technology ASA's annualized Debt-to-EBITDA for the quarter that ended in Jun. 2026 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Jun. 2026) EBITDA data.

Is Aqua Bio Technology ASA (STU:3FZ0) Overvalued in 2026?

Based on GuruFocus' analysis, Aqua Bio Technology ASA stock appears to be overvalued. The current stock price of €0.45 is trading 65.6% above its estimated GF Value™ of €0.27.

Key valuation signals for STU:3FZ0:

  • Debt-to-EBITDA: N/A
  • GF Value™: €0.27 vs. price of €0.45 (65.6% above fair value)
  • GF Score™: 43/100 with 6 warning signs

No single metric tells the full story. See the STU:3FZ0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Aqua Bio Technology ASA Business Description

Address Bygdoy Alle, Oslo, NOR, 0257
Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.
43GF Score

Get the complete analysis for STU:3FZ0

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.45
Price
€0.27
GF Value